Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,277 | 328 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,469 | 64 | $0 (2024) |
| ABBVIE INC. | $828.61 | 51 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $732.40 | 65 | $0 (2024) |
| PFIZER INC. | $305.62 | 21 | $0 (2024) |
| Astellas Pharma US Inc | $234.63 | 13 | $0 (2023) |
| Novo Nordisk Inc | $216.76 | 11 | $0 (2024) |
| Abbott Laboratories | $212.24 | 13 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $182.21 | 9 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $169.69 | 16 | $0 (2021) |
| Amarin Pharma Inc. | $92.60 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $930.94 | 52 | AstraZeneca Pharmaceuticals LP ($267.45) |
| 2023 | $920.64 | 51 | ABBVIE INC. ($294.34) |
| 2022 | $886.68 | 56 | AstraZeneca Pharmaceuticals LP ($290.51) |
| 2021 | $854.67 | 51 | AstraZeneca Pharmaceuticals LP ($267.40) |
| 2020 | $353.75 | 18 | AstraZeneca Pharmaceuticals LP ($189.14) |
| 2019 | $592.38 | 35 | AstraZeneca Pharmaceuticals LP ($204.92) |
| 2018 | $405.68 | 32 | Takeda Pharmaceuticals U.S.A., Inc. ($182.21) |
| 2017 | $332.75 | 33 | Boehringer Ingelheim Pharmaceuticals, Inc. ($141.71) |
All Payment Transactions
328 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Cardio-renal | ||||||
| 12/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: Obesity | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Diabetes Care | ||||||
| 11/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Diabetes Care | ||||||
| 11/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Diabetes Care | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Obesity | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: PAIN | ||||||
| 10/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: DIABETES | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Diabetes Care | ||||||
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: DIABETES | ||||||
| 09/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.83 | General |
| 08/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Obesity | ||||||
| 08/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/20/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: DIABETES | ||||||
| 08/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 726 | 1,352 | $174,015 | $104,613 |
| 2022 | 7 | 765 | 1,361 | $200,530 | $117,080 |
| 2021 | 10 | 1,126 | 2,831 | $319,855 | $180,169 |
| 2020 | 9 | 1,334 | 4,203 | $423,305 | $212,896 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 226 | 589 | $88,350 | $52,362 | 59.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 182 | 182 | $36,400 | $23,281 | 64.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 170 | 171 | $17,100 | $9,088 | 53.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 27 | 182 | $9,100 | $6,779 | 74.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 37 | 115 | $7,475 | $5,296 | 70.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $8,550 | $3,536 | 41.4% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 27 | $3,240 | $2,446 | 75.5% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 34 | $1,700 | $1,250 | 73.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 14 | 14 | $2,100 | $573.39 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 339 | 873 | $130,950 | $76,489 | 58.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 193 | 193 | $38,600 | $25,647 | 66.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 136 | 143 | $14,300 | $7,281 | 50.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 44 | 87 | $5,655 | $4,383 | 77.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $5,400 | $1,770 | 32.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 18 | 20 | $3,000 | $815.04 | 27.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 11 | 21 | $2,625 | $696.32 | 26.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 385 | 1,024 | $153,600 | $93,106 | 60.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 255 | 255 | $51,000 | $34,927 | 68.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 196 | 1,249 | $81,185 | $33,848 | 41.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 205 | 208 | $20,800 | $11,971 | 57.6% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 12 | 13 | $3,040 | $2,212 | 72.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $4,050 | $1,888 | 46.6% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 14 | 14 | $1,120 | $930.02 | 83.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 14 | 22 | $2,750 | $680.40 | 24.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 13 | 14 | $2,100 | $393.75 | 18.8% |
About Dr. Thomas Peters, MD
Dr. Thomas Peters, MD is a Internal Medicine healthcare provider based in Henderson, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659432250.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Peters, MD has received a total of $5,277 in payments from pharmaceutical and medical device companies, with $930.94 received in 2024. These payments were reported across 328 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,277).
As a Medicare-enrolled provider, Peters has provided services to 3,951 Medicare beneficiaries, totaling 9,747 services with total Medicare billing of $614,758. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Henderson, NV
- Active Since 12/13/2006
- Last Updated 09/28/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1659432250
Products in Payments
- FARXIGA (Drug) $1,136
- JARDIANCE (Drug) $718.72
- UBRELVY (Drug) $481.97
- BREZTRI (Drug) $282.31
- MYRBETRIQ (Drug) $195.13
- CHANTIX (Drug) $193.41
- Wegovy (Drug) $192.86
- FREESTYLE LIBRE 2 (Device) $149.21
- QULIPTA (Drug) $142.87
- VRAYLAR (Drug) $140.48
- Uloric (Drug) $114.90
- NURTEC ODT (Drug) $114.78
- Trintellix (Drug) $106.36
- Vascepa (Drug) $92.60
- JANUVIA (Drug) $80.08
- FREESTYLE LIBRE 3 (Device) $63.03
- ENTRESTO (Drug) $59.20
- SYNTHROID (Drug) $51.94
- APRETUDE (Biological) $49.97
- Cologuard Collection Kit (Device) $49.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Henderson
Ryan Hampton, D.o, D.O
Internal Medicine — Payments: $213,538
Jeffrey Levisman, M.d, M.D
Internal Medicine — Payments: $198,615
Marigene Salazar Sharma, Md, MD
Internal Medicine — Payments: $104,164
Dr. Karthiek Narala, M.d, M.D
Internal Medicine — Payments: $41,673
Sonu Bhatia, M.d, M.D
Internal Medicine — Payments: $21,843
Dr. Justin Terry, Md, MD
Internal Medicine — Payments: $21,280